March 11 (Reuters) - The European Union's drugs regulator on
Thursday recommended conditionally approving Johnson & Johnson's
single dose COVID-19 vaccine, as the bloc seeks to speed
up a stuttering inoculation campaign and boost its supplies of
vaccines.
The COVID-19 shot is the fourth to be endorsed for use in
the EU after vaccines from Pfizer-BioNTech ,
AstraZeneca-Oxford University and Moderna, and
is recommended for those over 18 years of age, the European
Medicines agency (EMA) said.
The United States, Canada and Bahrain have also approved the
shot. South Africa is carrying out an expedited review.
(Reporting by Muvija M and Pushkala Aripaka in Bengaluru;
additional reporting by Francesco Guarascio in Brussels; Editing
by Kevin Liffey
Editing by Josephine Mason and Mark Potter)